Steve Tutewohl - 01 Jul 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Operating Officer
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol: EVH
Transactions as of: 01 Jul 2023
Transactions value $: $0
Form type: 4
Filing time: 26 Apr 2024, 16:03:56 UTC
Previous filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Award	$0	+9K	+7.07%	$0.00	136K	01 Jul 2023	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Steve Tutewohl is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	This Form 4 is being filed late due to an administrative error.
F2	Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. On July 31, 2023, Mr. Tutewohl's last day of employment with the company, 3,000 of these RSUs vested and the remaining 6,000 were forfeited, in accordance with the terms of Mr. Tutewohl's severance and change in control agreement. Mr. Tutewohl ceased to be an officer of the company on July 3, 2023.
F3	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.